How to demonstrate the reversibility of end-organ function before implantation of left ventricular assist device in INTERMACS profile 2 patients?
2012 (English)In: Journal of Artificial Organs, ISSN 1434-7229, E-ISSN 1619-0904, Vol. 15, no 4, 395-398 p.Article in journal (Refereed) Published
For the time being, in Japan, two recently approved implantable ventricular assist devices (VADs) are indicated only when a patient has been listed for heart transplantation or approved to be eligible for heart transplantation by in-hospital committee. The reversibility of end-organ dysfunction must be expected before VAD implantation, but it is often hard to prove during worsening clinical status. We report two patients whose end-organ dysfunction had been eventually demonstrated to be reversible by invasive procedures such as transluminal liver biopsy or transient insertion of intra-aortic balloon pumping.
Place, publisher, year, edition, pages
Springer, 2012. Vol. 15, no 4, 395-398 p.
VAD; Organ failure; Continuous flow; Implantable
IdentifiersURN: urn:nbn:se:liu:diva-111191DOI: 10.1007/s10047-012-0654-4ISI: 000312371500010PubMedID: 22801753OAI: oai:DiVA.org:liu-111191DiVA: diva2:754501